US 7,351,722 B2Granted

Use of Mangafodipir for treating oxidative stress effects

AssigneeUniversite Rene Descartes (Paris V)

InventorsFrederic Batteux, Bernard Weill

Life of this patent

Estimating the term…

Abstract

The invention concerns the use of Mangafodipir to obtain a medicine for preventive or curative treatment of hepatocellular deficiencies.

Claims13

Dependent claims

A method for treating hepatocellular deficiency induced by alcohol or acetominophen, consisting of administering mangafodipir to a patient in need thereof.

Dependencies are inferred from the claim text.

Facts

Application: 10/475,555Filed 26 Apr 2002
Priority: FR 01 0560626 Apr 2001
Published: US 2004/0142907 A122 Jul 2004
Granted: 1 Apr 2008
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

A61K 31/6615
Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos: compounds having two or more…
A61K 31/444
Containing further heterocyclic ring systems: containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
A61K
Medicines and medical preparations

Family

US 2004/0142907 A1Pre-grant publication · published 22 Jul 2004
US 7,351,722 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results